Just Arrived: A Trio of Active and Passive Vaccines Against RSV
For decades, respiratory syncytial virus (RSV) has defied the best efforts of vaccine makers to bring it to heel, until now.
Merck’s Ebola Vaccine Approved for the Pediatric Population
An expanded indication for ERVECO for the prevention of disease caused by Zaire ebolavirus in individuals 12 months of age and older has been approved by the U.S. Food and Drug Administration.
Study Finds Adult Vaccines Potentially Protect Against Alzheimer’s
A new study conducted at the University of Texas Health Science Center at Houston found that people who received shingles and pneumonia vaccines — along with tetanus and diphtheria — had as much as a 30 percent reduced risk of developing Alzheimer’s the most common type of dementia.
FDA Approves Pfizer’s ABRYSVO Vaccine for the Prevention of RSV
Pfizer’s ABRYSVO, a respiratory syncytial virus (RSV) vaccine, has been approved by the U.S. Food and Drug Administration for the prevention of lower respiratory tract disease (LRTD) and severe LRTD caused by RSV in infants from birth up to 6 months of age by active immunization of pregnant women at 32 through 36 weeks gestational age.
How Medical Misinformation About Vaccines is Spread
Politicization and polarization have made finding credible information online harder than ever.
Adult Vaccines: Fact vs. Fiction
Addressing patient misconceptions and uncertainty remains important to help get routine adult vaccinations back on schedule.
Experimental mRNA Vaccine Plus Keytruda Delays Melanoma Recurrence
A new study shows that a personalized messenger RNA (mRNA) cancer vaccine plus the checkpoint inhibitor Keytruda (pembrolizumab) reduced the risk of recurrence or death in people with high-risk advanced melanoma.
The Spread of Misinformation and Its Effects on Vaccines
The effects of exposure to misinformation about vaccines has been exacerbated by the COVID-19 pandemic. And, misinformation continues to flourish with damaging consequences.
Personalized Cancer Vaccine Development
Research into targeted, effective vaccines for cancer remains ongoing.
CDC Adds COVID-19 Vaccine to Its Routine Immunization Schedule
The Centers for Disease Control and Prevention updated its schedule of recommended immunizations to include COVID-19 shots and boosters for children, adolescents and adults.
